| Primary |
| Staphylococcal Infection |
15.5% |
| Infection |
12.0% |
| Tuberculosis |
11.3% |
| Pneumonia |
10.7% |
| Osteomyelitis |
6.8% |
| Depression |
5.5% |
| Enterococcal Infection |
5.3% |
| Sepsis |
4.8% |
| Pneumonia Staphylococcal |
4.7% |
| Ill-defined Disorder |
3.1% |
| Wound Infection |
2.4% |
| Tuberculosis Of Central Nervous System |
2.3% |
| Type 2 Diabetes Mellitus |
2.3% |
| Acute Myeloid Leukaemia |
2.1% |
| Device Related Infection |
2.1% |
| Diabetic Foot Infection |
2.1% |
| Cellulitis |
1.9% |
| Urinary Tract Infection |
1.9% |
| Analgesia |
1.6% |
| Bacterial Infection |
1.6% |
|
| Thrombocytopenia |
24.8% |
| Platelet Count Decreased |
9.8% |
| Serotonin Syndrome |
7.6% |
| Death |
6.7% |
| Vomiting |
5.8% |
| Pancytopenia |
5.2% |
| Anaemia |
4.9% |
| Renal Impairment |
4.3% |
| Lactic Acidosis |
4.0% |
| Renal Failure |
3.7% |
| Tremor |
3.1% |
| Hypoglycaemia |
2.8% |
| Pathogen Resistance |
2.8% |
| Respiratory Failure |
2.8% |
| Drug Ineffective |
2.1% |
| Multi-organ Failure |
2.1% |
| Paraesthesia |
2.1% |
| Drug Resistance |
1.8% |
| Renal Failure Acute |
1.8% |
| Septic Shock |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
27.4% |
| Drug Abuse |
14.7% |
| Tuberculosis |
8.8% |
| Drug Use For Unknown Indication |
6.2% |
| Staphylococcal Infection |
5.6% |
| Infection |
4.9% |
| Pneumonia |
4.8% |
| Enterococcal Infection |
3.2% |
| Retroperitoneal Abscess |
3.2% |
| Depression |
3.0% |
| Sepsis |
2.7% |
| Osteomyelitis |
2.6% |
| Pyrexia |
2.3% |
| Abdominal Infection |
1.9% |
| Antibiotic Therapy |
1.9% |
| Immunosuppression |
1.6% |
| Rhodococcus Infection |
1.4% |
| Abscess |
1.4% |
| Endocarditis |
1.4% |
| Acute Myeloid Leukaemia |
1.3% |
|
| Serotonin Syndrome |
29.4% |
| Thrombocytopenia |
11.3% |
| Sepsis |
5.0% |
| Pancytopenia |
4.6% |
| Toxic Epidermal Necrolysis |
3.8% |
| Treatment Failure |
3.8% |
| Death |
3.4% |
| Multiple-drug Resistance |
3.4% |
| Septic Shock |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Tremor |
3.4% |
| Drug Interaction |
2.9% |
| Optic Neuritis |
2.9% |
| Pyrexia |
2.9% |
| Renal Impairment |
2.9% |
| Staphylococcal Infection |
2.9% |
| Urinary Tract Infection |
2.9% |
| Renal Failure |
2.5% |
| Renal Failure Acute |
2.5% |
| Respiratory Failure |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.6% |
| Drug Use For Unknown Indication |
15.7% |
| Prophylaxis |
5.4% |
| Acute Myeloid Leukaemia |
4.0% |
| Adverse Event |
3.7% |
| Tuberculosis |
3.3% |
| Sepsis |
3.2% |
| Infection |
3.2% |
| Pneumonia |
2.8% |
| Infection Prophylaxis |
2.5% |
| Pain |
2.3% |
| Constipation |
2.1% |
| Antifungal Prophylaxis |
2.1% |
| Staphylococcal Infection |
2.0% |
| Hiv Infection |
2.0% |
| Hypertension |
2.0% |
| Nausea |
1.9% |
| Pyrexia |
1.5% |
| Bone Marrow Conditioning Regimen |
1.4% |
| Prophylaxis Against Graft Versus Host Disease |
1.4% |
|
| Sepsis |
9.0% |
| Vomiting |
8.5% |
| Death |
8.2% |
| Thrombocytopenia |
7.7% |
| Septic Shock |
7.1% |
| Treatment Failure |
5.6% |
| Renal Failure Acute |
5.0% |
| Toxic Epidermal Necrolysis |
5.0% |
| Arrhythmia |
4.8% |
| Pyrexia |
4.5% |
| Staphylococcal Infection |
4.2% |
| Wound Infection Staphylococcal |
4.2% |
| Renal Failure |
4.0% |
| Urinary Tract Infection |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Respiratory Failure |
3.2% |
| Drug Ineffective |
2.9% |
| Pneumonia |
2.9% |
| Drug Interaction |
2.6% |
| Renal Impairment |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
18.9% |
| Pulmonary Tuberculosis |
9.8% |
| Nocardiosis |
9.1% |
| Haemolytic Anaemia |
7.6% |
| Staphylococcal Infection |
6.8% |
| Anaemia Haemolytic Autoimmune |
6.1% |
| Depression |
6.1% |
| Escherichia Infection |
4.5% |
| Infection |
4.5% |
| Wound Infection |
4.5% |
| Analgesic Therapy |
3.0% |
| Nosocomial Infection |
3.0% |
| Sedation |
3.0% |
| Bacterial Infection |
2.3% |
| Ill-defined Disorder |
2.3% |
| Mediastinal Abscess |
2.3% |
| Atrial Fibrillation |
1.5% |
| Chills |
1.5% |
| Empyema |
1.5% |
| Enterococcal Infection |
1.5% |
|
| Serotonin Syndrome |
19.6% |
| Self-medication |
9.8% |
| Drug Level Decreased |
7.8% |
| Haemoglobin Decreased |
7.8% |
| Platelet Count Decreased |
7.8% |
| Drug Interaction |
5.9% |
| Sinus Tachycardia |
5.9% |
| Hyperlactacidaemia |
3.9% |
| Incorrect Dose Administered |
3.9% |
| Tachycardia |
3.9% |
| Tremor |
3.9% |
| Unresponsive To Stimuli |
3.9% |
| Agitation |
2.0% |
| Drug Level Increased |
2.0% |
| Fall |
2.0% |
| Hypotension |
2.0% |
| Infection |
2.0% |
| Muscle Contractions Involuntary |
2.0% |
| Nausea |
2.0% |
| Renal Impairment |
2.0% |
|
